Nurix Therapeutics Inc. (NRIX) Social Stream
Nurix Therapeutics Inc (NRIX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering NRIX.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 49 weeks, NRIX's average price target has gone down $6.95.
Over the past 45 weeks, NRIX's average upside potential has been 89.97%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
NRIX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
NRIX's average broker recommendation rating improved by 0.1 over the prior 123 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how Nurix Therapeutics Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 636.34% of that group.
- NRIX has a higher number of analysts covering the stock than 647.26% of stocks in the small market cap category.
- In the context of stocks in the small market cap category, Nurix Therapeutics Inc's average analyst price target is higher than 615.97% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Nurix Therapeutics Inc's variance in analysts' estimates is lower than -349.41% of them.
What is the outlook for NRIX? Use POWR Ratings for clearer insight into price direction.